Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells

Biochemical and Biophysical Research Communications

Volumn 344, Issue 1, 2006, Pages 200-205

  Stielow, Claudia ^a   Catar, Rusan A ^a   Muller, Gregor ^a   Wingler, Kirstin ^b   Scheurer, Peter ^b   Schmidt, Harald H H W ^c   Morawietz, Henning ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Vasopharm BIOTECH GmbH   (Germany)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Endothelial cells; NAD(P)H oxidase; oxLDL; Reactive oxygen species; VAS2870

Indexed keywords

3 BENZYL 7 (2 BENZOXAZOLYL)THIO 1,2,3 TRIAZOLO[4,5 D]PYRIMIDINE; ENZYME INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REAGENT; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VAS 2870;

ARTICLE; CARDIOVASCULAR RISK; CELL CULTURE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

BENZOXAZOLES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; LIPOPROTEINS, LDL; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SUPEROXIDES; TRIAZOLES;

DIOGENES;

EID: 33646035513     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.114     Document Type: Article

References (21)

1. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 (2000) 840-844
2. Griendling K.K., and FitzGerald G.A. Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108 (2003) 2034-2040
3. Rueckschloss U., Duerrschmidt N., and Morawietz H. NADPH oxidase in endothelial cells: impact on atherosclerosis. Antioxid. Redox Signal. 5 (2003) 171-180
4. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
5. 2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ. Res. 93 (2003) 573-580
6. Jones S.A., O'Donnell V.B., Wood J.D., Broughton J.P., Hughes E.J., and Jones O.T. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271 (1996) H1626-H1634
7. Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87 (2000) 26-32
8. Bayraktutan U., Blayney L., and Shah A.M. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1903-1911
9. Rueckschloss U., Galle J., Holtz J., Zerkowski H.R., and Morawietz H. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 104 (2001) 1767-1772
10. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4 (2004) 181-189
11. Lambeth J.D., Cheng G., Arnold R.S., and Edens W.A. Novel homologs of gp91phox. Trends Biochem. Sci. 25 (2000) 459-461
12. Sorescu D., Weiss D., Lassegue B., Clempus R.E., Szocs K., Sorescu G.P., Valppu L., Quinn M.T., Lambeth J.D., Vega J.D., Taylor W.R., and Griendling K.K. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105 (2002) 1429-1435
13. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., Takada J., Wakisaka M., Ibayashi S., Utsumi H., and Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109 (2004) 227-233
14. F. Tegtmeier, U. Walter, R. Schinzel, K. Wingler, P. Scheurer, H.H.H.W. Schmidt, Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation, EP 1 598 354 A1 (2005).
15. Niemann B., Rohrbach S., Catar R.A., Muller G., Barton M., and Morawietz H. Native and oxidized low-density lipoproteins stimulate endothelin-converting enzyme-1 expression in human endothelial cells. Biochem. Biophys. Res. Commun. 334 (2005) 747-753
16. Duerrschmidt N., Wippich N., Goettsch W., Broemme H.J., and Morawietz H. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem. Biophys. Res. Commun. 269 (2000) 713-717
17. Wingler K., Wunsch S., Kreutz R., Rothermund L., Paul M., and Schmidt H.H. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31 (2001) 1456-1464
18. Napoli C., de Nigris F., and Palinski W. Multiple role of reactive oxygen species in the arterial wall. J. Cell. Biochem. 82 (2001) 674-682
19. Heinloth A., Heermeier K., Raff U., Wanner C., and Galle J. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J. Am. Soc. Nephrol. 11 (2000) 1819-1825
20. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
21. Thum T., and Borlak J. Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism?. Circ. Res. 94 (2004) e1-e13